Michael Gray, CFO & COO: Enliven Therapeutics ELVN Sell · Filed 23/02/01

Trade details

Type: Insider sale
Amount: $14,096.32
Shares · price: 3,596 sh · $3.92 a share
Held after: 37,466 sh
Stock: Enliven Therapeutics ELVN
Person: Michael GrayCFO & COO
Trade date: 23/01/30
Filed: 23/02/01
Days to filing: 2 days

Sold 8.8% of holdings

Share of holding sold: 8.8%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/31~23/03/01

Michael Gray's recent trades

Michael GrayCFO and COO
SellUpstream Bio
Sell
Upstream Bio
UPB
$5,203
853 sh
$5,203
Filed 06/17
Traded 06/16
Michael GrayCFO and COO
SellUpstream Bio
Sell
Upstream Bio
UPB
$7,915
852 sh
$7,915
Filed 03/17
Traded 03/16
Michael GrayCFO & COO
SellEnliven Therapeutics
Sell
Enliven Therapeutics
ELVN
$46K
9,856 sh
$46K
Filed 23/02/22
Traded 23/02/22

Michael Gray, CFO — sold $14.1K of Enliven Therapeutics ELVN · 8.8% of holdings | Whalegun